Mark Sumeray
2013
In 2013, Mark Sumeray earned a total compensation of $3.1M as former Chief Medical Officer at Aegerion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $220,400 |
|---|---|
| Option Awards | $2,391,457 |
| Salary | $380,000 |
| Other | $81,150 |
| Total | $3,073,007 |
Sumeray received $2.4M in option awards, accounting for 78% of the total pay in 2013.
Sumeray also received $220.4K in non-equity incentive plan, $380K in salary and $81.2K in other compensation.
Rankings
In 2013, Mark Sumeray's compensation ranked 2,463rd out of 12,286 executives tracked by ExecPay. In other words, Sumeray earned more than 80.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,463 out of 12,286 | 80th |
Division Manufacturing | 817 out of 4,612 | 82nd |
Major group Chemicals And Allied Products | 219 out of 1,462 | 85th |
Industry group Drugs | 145 out of 1,156 | 88th |
Industry Pharmaceutical Preparations | 123 out of 890 | 86th |
Source: SEC filing on April 29, 2016.
Sumeray's colleagues
We found four more compensation records of executives who worked with Mark Sumeray at Aegerion Pharmaceuticals in 2013.